Gentian Kaloshi

Tirana, Albania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Letter to the Editor. An extent of resection threshold for recurrent glioblastoma: why wait until recurrence?

Letter to the Editor. An extent of resection threshold for recurrent glioblastoma: why wait until recurrence?

Journal: Journal of neurosurgery

Published: August 19, 2017

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Journal: Journal of neuro-oncology

Published: August 03, 2017

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.

Journal: Fundamental & clinical pharmacology

Published: September 16, 2016

Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.

Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.

Journal: Journal of neurosurgery

Published: June 27, 2015

Letter to the Editor: Neoadjuvant chemotherapy to maximize glioblastoma resection in the elderly.

Letter to the Editor: Neoadjuvant chemotherapy to maximize glioblastoma resection in the elderly.

Journal: Journal of neurosurgery

Published: June 09, 2015

Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics.

Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics.

Journal: CPT: pharmacometrics & systems pharmacology

Published: March 11, 2015

The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.

The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.

Journal: Tumori

Published: July 28, 2014

Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.

Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.

Journal: Medical archives (Sarajevo, Bosnia and Herzegovina)

Published: June 19, 2014

Spinal Dissemination of Intracranial Glioblastoma in Bevacizumab Era: a Potential Bevacizumab-induced Mechanism.

Spinal Dissemination of Intracranial Glioblastoma in Bevacizumab Era: a Potential Bevacizumab-induced Mechanism.

Journal: Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH

Published: May 15, 2014

Bevacizumab alone at 5 mg/kg in an every-3-week schedule for patients with recurrent glioblastomas: a single center experience.

Bevacizumab alone at 5 mg/kg in an every-3-week schedule for patients with recurrent glioblastomas: a single center experience.

Journal: Tumori

Published: December 24, 2013

Upfront chemotherapy with CCNU alone for adults' low-grade gliomas: a clinical analysis.

Upfront chemotherapy with CCNU alone for adults' low-grade gliomas: a clinical analysis.

Journal: Journal of neuro-oncology

Published: October 21, 2013

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy.

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy.

Journal: Journal of neuro-oncology

Published: May 20, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026